We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Update about the developing role of biosimilar medicines in the NHS in England and the safe, effective and consistent use of biosimilar medicines.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.
The Advisory Group on Military and Emergency Response Medicine (AGMERM) provides specialist advice to the Ministry of Defence on the medical aspects of defence against chemical, biological and radiological threats. AGMERM works with the Ministry of Defence .
Information for patients, healthcare professionals and developers of new medicines
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Information on granted EAMS scientific opinions, including the public assessment report and treatment protocols.
How veterinary medicines can be advertised.
Dawa Limited has informed the MHRA that specified batches listed in this notification have been packed with an outdated Patient Information Leaflet (PIL).
Information on herbal medicines, how to apply for a traditional herbal registration (THR), banned or restricted herbal ingredients, homeopathic medicines and fees.
Information and documents on Public Health England’s review of the evidence for dependence on, and withdrawal from, prescribed medicines.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Information for wholesale dealer licence holders about the medicines put on the UK market for UK patients that they cannot export or hoard.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Guidance for prescribing vets on the use of the cascade.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).